eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse all drugs       All conditions, symptoms, side effects

From FDA reports: drug interactions between Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome for a Female patient aged 35

This is a personalized study for a 35 year old female patient. The study is created by eHealthMe based on reports of 3 people who take the same drugs and have drug interactionsfrom FDA.

Get a free personalized report of your drugs: we study for you 352 million drug outcomes from FDA and social media. Start to use eHealthMe >>>

On Aug, 28, 2014: 3 people who reported to have interactions when taking Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome are studied

Trend of Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome's drug interactions, side effects, and effectiveness reports (3912113)

Information of the patient in this study:

Age: 35

Gender: female

Conditions: Infection

Drugs taking:
- Rituxan
- Cefepime
- Phenytoin
- Solu-medrol
- Meropenem
- Ambisome: used for < 1 month

Drug interactions have: Stevens-johnson Syndrome, Septic Shock, Respiratory Disorder

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 35 (±5):

InteractionNumber of reports
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)3 (100.00%)
Septic Shock (shock due to blood infection)3 (100.00%)
Respiratory Disorder (respiratory disease)3 (100.00%)

Most common interactions experienced by females aged 35 (±5) in the use of Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome:

InteractionNumber of reports
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)3
Respiratory Disorder (respiratory disease)3
Septic Shock (shock due to blood infection)3
Hyperaemia (increase of blood flow to different tissues in the body)2
Generalised Oedema (swelling all over the body)2

Most common interactions experienced by females aged 35 (±5) in long term use of Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)3 (100.00%)
Septic Shock (shock due to blood infection)3 (100.00%)
Respiratory Disorder (respiratory disease)3 (100.00%)

Most common interactions experienced by people in the use of Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome:

InteractionNumber of reports
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)3
Respiratory Disorder (respiratory disease)3
Septic Shock (shock due to blood infection)3
Hyperaemia (increase of blood flow to different tissues in the body)2
Generalised Oedema (swelling all over the body)2

Most common interactions experienced by people in long term use of Rituxan, Cefepime, Phenytoin, Solu-medrol, Meropenem, Ambisome:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.